Radical MS treatment can halt disease – but could be fatal
Patients face heart-breaking dilemma over treatment that leaves immune system dangerously vulnerable

A radical treatment for multiple sclerosis has given a number of trial volunteers their lives back - but it comes with a deadly dilemma.
MS causes the immune system to attack the protective layer around nerve fibres in the spinal cord, optic nerves and brain, which can leave patients paralysed and blind.
Using a procedure more commonly used to treat leukaemia, the new therapy "erases" the patient's immune system via chemotherapy and then "reboots" it with a transfusion of stem cells previously collected from the patient and purified.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
However, the treatment comes with astounding risks and leaves the patients dangerously vulnerable until the stem cells take effect. One of the 24 volunteers in the latest medical trial died after developing a liver infection.
On the other hand, the potential benefits are equally astounding. Although the treatment only aims to halt the progress of the disease, some patients reported a life-changing improvement in their condition.
Follow-up reports on the 24 patients in the trial, carried out at the Ottawa Hospital, revealed that MS symptoms had halted in 70 per cent of patients and 40 per cent went into remission.
Canadian Jennifer Molson told New Scientist that when she had needed a wheelchair when she volunteered.
"I took a leap of faith. I felt like I would be kicking myself if I didn't take this chance," she said. After 18 months, her symptoms began to disappear and now she can walk, work full-time and enjoy skiing holidays with her husband.
"This is very exciting," Dr Harold Atkins told the Daily Telegraph. He cautioned that the therapy had "serious side effects and risks" and was only appropriate for a small proportion of MS patients.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
How the New World Screwworm is making a deadly comeback
The explainer The parasite is spreading quickly
-
A running list of all the celebrities Trump has pardoned
IN DEPTH Reality stars, rappers and disgraced politicians have received some of the high-profile pardons doled out by the president
-
US credit rating: what it is and why it matters
the explainer Credit rating agency Moody's downgraded the US last month
-
'Angel' visits woman before lottery win
Tall Tales And other stories from the stranger side of life
-
Doomsday group offers 'epic' survival opportunity
Tall Tales And other stories from the stranger side of life
-
What we know about the Titan sub’s likely implosion
feature Experts say the five passengers would have died ‘instantaneously’ following ‘catastrophic’ loss of pressure
-
What happened to the missing Titanic sub?
Today's Big Question Oxygen supplies running out after vessel lost contact during ‘daredevil’ trip
-
Man arrested after shooting himself in the leg
feature And other stories from the stranger side of life
-
Scientists have watched the end of the world
feature And other stories from the stranger side of life
-
Canada’s troubled relationship with its indigenous population
feature State grappling with reparations amid accusations of genocides against First Nations people
-
Woman passes driving test at 960th attempt
feature And other stories from the stranger side of life